Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole
Status:
Completed
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
Study design to define improved management of patients with hepatic alveolar echinococcosis
treated with albendazole and especially make appropriate and timely decision of treatment
withdrawal .
Based on exploratory analysis of existing and newly developed biological and imaging exams,
for diagnosis and follow-up, and study of the relationship of these markers to the viability
of the parasite and/or the activity of the parasitic lesions The study included two series of
patients: operated on (curative hepatectomy) // non-operated on